P2PAR-100

N/A

Report date: 2023/03/05 18:10:17
NME

Base Information

Drug NameP2PAR-100
Drug Alias NameP2PAR-100
ClassificationOther
Mechanisms of ActionToll like receptor 4 agonists
TargetsToll like receptor 4
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPattern Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesPattern Pharma Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A